Pfizer, the country’s largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer’s Upjohn, which ...
The American Cancer Society (ACS) and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis (www.Novartis.com), and Mylan to expand ...
Pharmaceutical giants Pfizer and Mylan reached a deal today to combine the two companies off-patent generic drug businesses. The deal is expected to bring in $20 billion in annual sales next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results